Advisor Group’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-154
Closed -$8K 5489
2018
Q4
$8K Sell
154
-49
-24% -$2.66K ﹤0.01% 4348
2018
Q3
$9K Buy
203
+14
+7% +$677 ﹤0.01% 4365
2018
Q2
$9K Sell
189
-39
-17% -$1.87K ﹤0.01% 4157
2018
Q1
$10K Sell
228
-1
-0.4% -$45 ﹤0.01% 4112
2017
Q4
$9K Sell
229
-31
-12% -$1.29K ﹤0.01% 4172
2017
Q3
$11K Buy
260
+47
+22% +$2.15K ﹤0.01% 3942
2017
Q2
$10K Buy
213
+9
+4% +$420 ﹤0.01% 3953
2017
Q1
$8K Buy
204
+78
+62% +$3.26K ﹤0.01% 3934
2016
Q4
$5K Hold
126
﹤0.01% 3974
2016
Q3
$7K Sell
126
-101
-44% -$4.69K ﹤0.01% 3780
2016
Q2
$9K Buy
+227
New +$9.53K ﹤0.01% 3553

Advisor Group's IMPV Position: Q1 2019 in Review

Advisor Group sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 154 shares — an estimated $8K sold.

Advisor Group first reported a position in IMPV in Q2 2016 and held it in 11 quarters. The position peaked at $11K in Q3 2017. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Advisor Group reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Advisor Group sold 154 Imperva, Inc. shares in Q1 2019, an estimated $8K.
  • Advisor Group first reported a position in Imperva, Inc. in Q2 2016 and held it in 11 quarters.
  • Advisor Group's Imperva, Inc. position peaked at $11K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Advisor Group's 13F filing for Q1 2019, filed 9 May 2019.